Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region
Authors: Leitch EC, Harvala H, Robertson I, Ubillos I, Templeton K, Simmonds P
Publication year: 2009
Journal: Journal of Clinical Virology
Journal name in source: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Journal acronym: J Clin Virol
Volume: 44
Issue: 2
First page : 119
Last page: 24
ISSN: 1386-6532
eISSN: 1873-5967
DOI: https://doi.org/10.1016/j.jcv.2008.11.015
Abstract
BACKGROUND\nOBJECTIVES\nSTUDY DESIGN\nRESULTS\nCONCLUSIONS\nHuman enteroviruses (HEV) are a major cause of meningitis and other neurological disease. Identification of HEV serotypes in clinical cases is important for monitoring emergence of more pathogenic variants, epidemiological surveillance and investigating sources of infection. Serotype identification is currently problematic following the widespread adoption of polymerase chain reaction (PCR)-based methods for HEV detection in place of virus culture.\nTo develop a reliable, sensitive method to identify species A and B serotypes directly from cerebrospinal fluid (CSF) specimens.\nA nested-PCR was used to amplify VP1 region sequences of HEV species A and B, that enabled unambiguous serotype identification by comparison with reference strains.\n62 from 64 diagnostic CSF samples collected over a 19-month study period were successfully amplified (97% sensitivity), compared with 9/22 (41%) identified by virus culture of co-referred faecal and throat swab samples. Among these, 60 samples contained species B and 2 samples contained species A serotypes (coxsackievirus A6 and enterovirus 71) were identified. Rapid changes in serotype frequencies and diversity were observed; echovirus (E) type 9 infections predominated in early 2007, to be replaced by E30 later in the year and followed by a diverse range of eight different species B serotypes in 2008.\nThe availability of a simple and rapid method for identification of serotypes and individual HEV strains or clusters directly from CSF will be of substantial value in surveillance, understanding more about serotype-associated differences in disease and monitoring the global spread of pathogenic variants such as enterovirus 71.
BACKGROUND\nOBJECTIVES\nSTUDY DESIGN\nRESULTS\nCONCLUSIONS\nHuman enteroviruses (HEV) are a major cause of meningitis and other neurological disease. Identification of HEV serotypes in clinical cases is important for monitoring emergence of more pathogenic variants, epidemiological surveillance and investigating sources of infection. Serotype identification is currently problematic following the widespread adoption of polymerase chain reaction (PCR)-based methods for HEV detection in place of virus culture.\nTo develop a reliable, sensitive method to identify species A and B serotypes directly from cerebrospinal fluid (CSF) specimens.\nA nested-PCR was used to amplify VP1 region sequences of HEV species A and B, that enabled unambiguous serotype identification by comparison with reference strains.\n62 from 64 diagnostic CSF samples collected over a 19-month study period were successfully amplified (97% sensitivity), compared with 9/22 (41%) identified by virus culture of co-referred faecal and throat swab samples. Among these, 60 samples contained species B and 2 samples contained species A serotypes (coxsackievirus A6 and enterovirus 71) were identified. Rapid changes in serotype frequencies and diversity were observed; echovirus (E) type 9 infections predominated in early 2007, to be replaced by E30 later in the year and followed by a diverse range of eight different species B serotypes in 2008.\nThe availability of a simple and rapid method for identification of serotypes and individual HEV strains or clusters directly from CSF will be of substantial value in surveillance, understanding more about serotype-associated differences in disease and monitoring the global spread of pathogenic variants such as enterovirus 71.
UTU Research Portal